In addition to the immune checkpoint protein TIM3 ligand Gal-9 [111], another TIM3 ligand, CEACAM1MDS, is also increased in the MDSC-mediated CD8+ T-cell failure pathway in MDS [112]. Here, CD8A is linked to myelodysplastic syndrome.